Table 5.
Association between OD and risk factors for all patients are presented in this table.
| Odds ratio (OR) | 95% confidence interval (CI) for OR |
p-Values | ||
|---|---|---|---|---|
| Lower | Upper | |||
| Sex | 1.578 | 0.946 | 2.632 | .079 |
| Past medical history (PMH) | 0.418 | 0.258 | 0.678 | *.000 |
| Fever | 1.067 | 0.659 | 1.727 | .792 |
| Sore throat | 2.720 | 1.010 | 7.326 | *.040 |
| Dyspnoea | 0.369 | 0.170 | 0.799 | *.009 |
| Myalgia | 1.076 | 0.650 | 1.781 | .776 |
| Fatigue | 0.338 | 0.154 | 0.746 | *.005 |
| Nasal Obstruction | 1.538 | 0.484 | 4.893 | .462 |
| Gustatory Dysfunction | 6.009 | 3.034 | 11.901 | *.000 |
| Post-Nasal Drip (PND) | 2.072 | 0.572 | 7.510 | .258 |
| Chest Pain | 0.500 | 0.031 | 8.075 | .618 |
| Headache | 1.593 | 0.746 | 3.400 | .225 |
| Rhinorrhoea | 1.692 | 0.455 | 6.286 | .427 |
| Sneezing | 0.240 | 0.059 | 0.981 | *.032 |
| Alcohol-based hand sanitizers | 0.488 | 0.141 | 1.688 | .727 |
| Angiotensin II receptor blockers (ARBs) | 0.296 | 0.111 | 0.778 | *.010 |
| Angiotensin converting enzyme inhibitors (ACEinh) | 1.547 | 0.546 | 4.380 | .480 |
| Beta blockers | 0.609 | 0.233 | 1.593 | .308 |
| Hx of smoking | 0.616 | 0.269 | 1.410 | .248 |
| Opioid addiction | 0.330 | 0.054 | 2.007 | .207 |
| A family medical history of COVID-19 | 3.496 | 1.888 | 6.473 | *.000 |
| Chest CT | 1.824 | 0.682 | 4.875 | .225 |
| PCR | 0.756 | 0.394 | 1.453 | .400 |
The asterisks in the table denote statistically significant p-values.